Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Effects of the renal medullary pH and ionic environment on vasopressin binding and signaling.

Zalyapin EA, Bouley R, Hasler U, Vilardaga JP, Lin HY, Brown D, Ausiello DA.

Kidney Int. 2008 Dec;74(12):1557-67. doi: 10.1038/ki.2008.412. Epub 2008 Aug 27.

2.

Heterologous downregulation of vasopressin type 2 receptor is induced by transferrin.

Bouley R, Nunes P, Andriopoulos B Jr, McLaughlin M, Webber MJ, Lin HY, Babitt JL, Gardella TJ, Ausiello DA, Brown D.

Am J Physiol Renal Physiol. 2013 Mar 1;304(5):F553-64. doi: 10.1152/ajprenal.00438.2011. Epub 2012 Dec 12.

3.

Visualizing microtubule-dependent vasopressin type 2 receptor trafficking using a new high-affinity fluorescent vasopressin ligand.

Chen S, Webber MJ, Vilardaga JP, Khatri A, Brown D, Ausiello DA, Lin HY, Bouley R.

Endocrinology. 2011 Oct;152(10):3893-904. doi: 10.1210/en.2011-1049. Epub 2011 Aug 9.

5.

Functional role of the NPxxY motif in internalization of the type 2 vasopressin receptor in LLC-PK1 cells.

Bouley R, Sun TX, Chenard M, McLaughlin M, McKee M, Lin HY, Brown D, Ausiello DA.

Am J Physiol Cell Physiol. 2003 Oct;285(4):C750-62. Epub 2003 Jun 11.

6.

The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors.

Juul KV, Bichet DG, Nielsen S, Nørgaard JP.

Am J Physiol Renal Physiol. 2014 May 1;306(9):F931-40. doi: 10.1152/ajprenal.00604.2013. Epub 2014 Mar 5. Review.

7.

Low pH stimulates vasopressin V2 receptor promoter activity and enhances downregulation induced by V1a receptor stimulation.

Memetimin H, Izumi Y, Nakayama Y, Kohda Y, Inoue H, Nonoguchi H, Tomita K.

Am J Physiol Renal Physiol. 2009 Sep;297(3):F620-8. doi: 10.1152/ajprenal.90520.2008. Epub 2009 Jul 8.

8.
9.

Downregulation of the vasopressin type 2 receptor after vasopressin-induced internalization: involvement of a lysosomal degradation pathway.

Bouley R, Lin HY, Raychowdhury MK, Marshansky V, Brown D, Ausiello DA.

Am J Physiol Cell Physiol. 2005 Jun;288(6):C1390-401. Epub 2005 Jan 26.

10.

Alix (AIP1) is a vasopressin receptor (V2R)-interacting protein that increases lysosomal degradation of the V2R.

Yi X, Bouley R, Lin HY, Bechoua S, Sun TX, Del Re E, Shioda T, Raychowdhury MK, Lu HA, Abou-Samra AB, Brown D, Ausiello DA.

Am J Physiol Renal Physiol. 2007 May;292(5):F1303-13. Epub 2007 Feb 6.

11.

Vasopressin receptor-mediated functional signaling pathway in primary cilia of renal epithelial cells.

Raychowdhury MK, Ramos AJ, Zhang P, McLaughin M, Dai XQ, Chen XZ, Montalbetti N, Del Rocío Cantero M, Ausiello DA, Cantiello HF.

Am J Physiol Renal Physiol. 2009 Jan;296(1):F87-97. doi: 10.1152/ajprenal.90509.2008. Epub 2008 Oct 22.

12.

Noncanonical control of vasopressin receptor type 2 signaling by retromer and arrestin.

Feinstein TN, Yui N, Webber MJ, Wehbi VL, Stevenson HP, King JD Jr, Hallows KR, Brown D, Bouley R, Vilardaga JP.

J Biol Chem. 2013 Sep 27;288(39):27849-60. doi: 10.1074/jbc.M112.445098. Epub 2013 Aug 9.

13.
14.
15.

Characterization of the effects of the vasopressin V2 receptor on sweating, fluid balance, and performance during exercise.

Hew-Butler T, Hummel J, Rider BC, Verbalis JG.

Am J Physiol Regul Integr Comp Physiol. 2014 Aug 15;307(4):R366-75. doi: 10.1152/ajpregu.00120.2014. Epub 2014 Jun 18.

16.

VRQ397 (CRAVKY): a novel noncompetitive V2 receptor antagonist.

Rihakova L, Quiniou C, Hamdan FF, Kaul R, Brault S, Hou X, Lahaie I, Sapieha P, Hamel D, Shao Z, Gobeil F Jr, Hardy P, Joyal JS, Nedev H, Duhamel F, Beauregard K, Heveker N, Saragovi HU, Guillon G, Bouvier M, Lubell WD, Chemtob S.

Am J Physiol Regul Integr Comp Physiol. 2009 Oct;297(4):R1009-18. doi: 10.1152/ajpregu.90766.2008. Epub 2009 Jul 29.

17.

Regulation of V2R transcription by hypertonicity and V1aR-V2R signal interaction.

Izumi Y, Nakayama Y, Memetimin H, Inoue T, Kohda Y, Nonoguchi H, Tomita K.

Am J Physiol Renal Physiol. 2008 Oct;295(4):F1170-6. doi: 10.1152/ajprenal.00119.2008. Epub 2008 Aug 13.

18.
19.

Vasopressin V2R-targeting peptide carrier mediates siRNA delivery into collecting duct cells.

Jung HJ, Lim JS, Choi HJ, Lee MS, Kim JH, Kim SY, Kim S, Kim E, Kwon TH.

PLoS One. 2012;7(6):e40010. doi: 10.1371/journal.pone.0040010. Epub 2012 Jun 28.

Supplemental Content

Support Center